|
Lymphoid Neoplasia
Citations 221-230 of 299 total displayed.
|
Past content
(since Jan 2009):
|
ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- Alessandra Soriani, Alessandra Zingoni, Cristina Cerboni, Maria Luisa Iannitto, Maria Rosaria Ricciardi, Valentina Di Gialleonardo, Marco Cippitelli, Cinzia Fionda, Maria Teresa Petrucci, Anna Guarini, Robin Foà, and Angela Santoni
Blood 2009; 113: 3503-3511.
[Abstract]
[Full text]
[PDF]
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- Roch Houot and Ronald Levy
Blood 2009; 113: 3546-3552.
[Abstract]
[Full text]
[PDF]
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone
- Emanuela Carlotti, David Wrench, Janet Matthews, Sameena Iqbal, Andrew Davies, Andrew Norton, Jason Hart, Raymond Lai, Silvia Montoto, John G. Gribben, T. Andrew Lister, and Jude Fitzgibbon
Blood 2009; 113: 3553-3557.
[Abstract]
[Full text]
[PDF]
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
- Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O'Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Rassenti, Stefan Faderl, Hagop Kantarjian, and Lynne V. Abruzzo
Blood 2009; 113: 3168-3171.
[Abstract]
[Full text]
[PDF]
A critical role for DAP10 and DAP12 in CD8+ T cell–mediated tissue damage in large granular lymphocyte leukemia
- Xianghong Chen, Fanqi Bai, Lubomir Sokol, Junmin Zhou, Amy Ren, Jeffrey S. Painter, Jinhong Liu, David A. Sallman, Y. Ann Chen, Jeffrey A. Yoder, Julie Y. Djeu, Thomas P. Loughran, Pearlie K. Epling-Burnette, and Sheng Wei
Blood 2009; 113: 3226-3234.
[Abstract]
[Full text]
[PDF]
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
- Aimable Nahimana, Antoine Attinger, Dominique Aubry, Peter Greaney, Christopher Ireson, Annemette V. Thougaard, Jette Tjørnelund, Keith M. Dawson, Marc Dupuis, and Michel A. Duchosal
Blood 2009; 113: 3276-3286.
[Abstract]
[Full text]
[PDF]
Expression of CD133 on leukemia-initiating cells in childhood ALL
- Charlotte V. Cox, Paraskevi Diamanti, Roger S. Evely, Pamela R. Kearns, and Allison Blair
Blood 2009; 113: 3287-3296.
[Abstract]
[Full text]
[PDF]
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia
- Roman Crazzolara, Adam Cisterne, Marilyn Thien, John Hewson, Rana Baraz, Kenneth F. Bradstock, and Linda J. Bendall
Blood 2009; 113: 3297-3306.
[Abstract]
[Full text]
[PDF]
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis
- Vincent Ribrag, Serge Koscielny, Olivier Casasnovas, Cecile Cazeneuve, Pauline Brice, Franck Morschhauser, Jean Gabarre, Aspasia Stamatoullas, Gilbert Lenoir, and Gilles Salles, on Behalf from the Groupe d'Etude des Lymphomes agressifs group, Laboratoire de Génétique et de recherche translationnelle, and Institut Gustave Roussy
Blood 2009; 113: 3307-3313.
[Abstract]
[Full text]
[PDF]
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization
- Relja Popovic, Laurie E. Riesbeck, Chinavenmeni S. Velu, Aditya Chaubey, Jiwang Zhang, Nicholas J. Achille, Frank E. Erfurth, Katherine Eaton, Jun Lu, H. Leighton Grimes, Jianjun Chen, Janet D. Rowley, and Nancy J. Zeleznik-Le
Blood 2009; 113: 3314-3322.
[Abstract]
[Full text]
[PDF]
|
|
